Annual report pursuant to Section 13 and 15(d)

Schedule of Stock Options Granted (Details)

v3.19.1
Schedule of Stock Options Granted (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Equity [Abstract]    
Options outstanding - beginning of year 980,000 669,000
Shares, Granted 2,490,000 625,000
Shares, Exercised (490,000) (315,000)
Options outstanding - end of year 2,980,000 980,000
Options vested and exercisable 673,000  
Weighted Average Exercise Price Options outstanding - beginning of year $ 1.82 $ 1.52
Weighted Average Exercise Price, Granted 2.08 2.01
Weighted Average Exercise Price, Exercised 1.64 1.55
Weighted Average Exercise Price Options outstanding - end of year 1.82 $ 1.82
Weighted Average Exercise Price, Options vested and exercisable $ 2.00  
Weighted Average Remaining Contractual Life (in years) - beginning of year 4 years 9 months 18 days 3 years 2 months 12 days
Weighted Average Remaining Contractual Life (in years), Granted 4 years 3 months 19 days 6 years 3 months 19 days
Weighted Average Remaining Contractual Life (in years) - ending of year 4 years 9 months 18 days 4 years 9 months 18 days
Weighted Average Remaining Contractual Life (in years) - Options vested and exercisable 4 years 1 month 6 days  
Total Intrinsic Value - beginning of year $ 52 $ 324
Total Intrinsic Value - ending of year 3,235 $ 52
Total Intrinsic Value, Options vested and exercisable $ 777